Cellular senescence predicts treatment outcome in metastasised colorectal cancer
Open accessThe DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Cellular senescence is a terminal cell-cycle arrest that occurs in response to activated oncogenes and DNA-damaging chemotherapy. Whether cancer cell senescence at diagnosis might be predictive for treatment outcome is unknown. METHODS: A senescence index (SI) was developed and used to retrospectively correlate the treatment outcome of 30 UICC stage IV colorectal cancer (CRC) patients with their SI at diagnosis. RESULTS: 5-Fluorouracil/leucovorin-treated CRC patients achieved a significantly longer progression-free survival when presenting with SI-positive tumours before therapy (median 12.0 vs 6.0 months; P=0.044). CONCLUSION: Cancer cell senescence predicts treatment outcome in metastasised CRC. Prospective analyses of larger patient cohorts are needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and are a characteristic of therapy-induced senescence (Haugstetter et al., 2010).”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Haugstetter et al., 2010
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In most studies, senescence is assessed in ex vivo cultures or fresh samples by SAb -gal staining or indirect markers in formalin-fixed tissues”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Haugstetter et al., 2010
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Colon adenomas, which are stable precursor lesions of invasive colon cancer, were found to be negative for the proliferation marker Ki67 and positive for SA- β- gal 87,88 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [88]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Supporting this notion, the burden of senescent cells in tissues increases significantly with age in mice, primates, and humans,27 and they can be found in both benign and malignant tumours.31–35”
From Paracrine roles of cellular senescence in promoting tumourigenesis (2018) · cites this paper as [32]
In the citing paper
“Since senescent cells are generally abundant in benign tumours and also present at low numbers in several malignancies,31–34,57 their paracrine activities could contribute to tumour progression and cancer metastasis.”
From Paracrine roles of cellular senescence in promoting tumourigenesis (2018) · cites this paper as [32]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477 · cited 3×
“…(2010) 103(4), 505 – 509 & 2010 Cancer Research UK M o le c u la r D ia g n o stic s Senescence-associated b-galactosidase activity Senescence-associated b-galactosidase activity was detected at pH 6.0 in cryo-preserved cells or tissue sections as described (Dimri et al, 1995; Braig et al, 2005).”
BackgroundMethodInfluentialOncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 6×
“…in a well-established OIS reference model system – sections of either snap-frozen or FFPE pellets of Ras-senescent vs proliferating fibroblasts – that allowed us to compare SA-b-gal staining and potential immunohistochemical surrogate markers in the same material side by side (Serrano et al, 1997).”
BackgroundMethodInfluentialDNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688 · cited 3×
“Oncogene-induced senescence is mediated through an oncogene-evoked DNA damage response (DDR) (Bartkova et al, 2005, 2006; Gorgoulis et al, 2005), thereby explaining why DNA-damaging chemotherapy produces senescence as well (Chang et al, 1999; Schmitt et al, 2002).”
BackgroundRb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278 · cited 1×
“…adenoma samples, we generated a senescence surrogate score (SI) based on the expression of p-ERK, HP1g and PAI-1 – all of them previously linked to OIS (Serrano et al, 1997; Lin et al, 1998; Narita et al, 2003) – that recapitulated SA-b-gal reactivity and adenoma senescence (Figure 1C; Figure 2).”
MethodBRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160 · cited 2×
“A third cancer-related growth condition is oncogene-induced senescence (OIS), a terminal cell-cycle arrest initiated by activated Ras-type oncogenes that acts as a tumour-suppressive barrier in pre-malignant lesions in vivo (Braig et al., 2005; Collado & Serrano, 2010; Michaloglou et al., 2005; Reimann et al., 2010).”
BackgroundActivation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009 · cited 3×
“Oncogene-induced senescence is mediated through an oncogene-evoked DNA damage response (DDR) (Bartkova et al, 2005, 2006; Gorgoulis et al, 2005), thereby explaining why DNA-damaging chemotherapy produces senescence as well (Chang et al, 1999; Schmitt et al, 2002).”
BackgroundOncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V. F., Kolettas, E., Niforou, K., Zoumpourlis, V. C., et al. (2006) · Nature · doi:10.1038/nature05268 · Cited by 1,986 · cited 7×
“Oncogene-induced senescence is mediated through an oncogene-evoked DNA damage response (DDR) (Bartkova et al, 2005, 2006; Gorgoulis et al, 2005), thereby explaining why DNA-damaging chemotherapy produces senescence as well (Chang et al, 1999; Schmitt et al, 2002).”
BackgroundMethodInfluentialOncogene-induced senescence as an initial barrier in lymphoma development
Braig, M., Lee, S., Loddenkemper, C., Rudolph, C., Peters, A. H. F. M., Schlegelberger, B., Stein, H., Dörken, B., Jenuwein, T., & Schmitt, C. A. (2005) · Nature · doi:10.1038/nature03841 · Cited by 1,220 · cited 4×
“…(2010) 103(4), 505 – 509 & 2010 Cancer Research UK M o le c u la r D ia g n o stic s Senescence-associated b-galactosidase activity Senescence-associated b-galactosidase activity was detected at pH 6.0 in cryo-preserved cells or tissue sections as described (Dimri et al, 1995; Braig et al, 2005).”
BackgroundMethodInfluentialSelf-citationKi67 in breast cancer: prognostic and predictive potential
Yerushalmi, R., Woods, R., Ravdin, P. M., Hayes, M. M., & Gelmon, K. A. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70262-1 · Cited by 1,207 · cited 2×
“Although relevant as a prognosticator, the value of utilizing the mitotic index to predict treatment outcome is very limited (see (Brown & Attardi, 2005; Schmitt, 2003; Schmitt, 2007; Yerushalmi et al., 2010) for review and references therein).”
BackgroundRoth, A. D., Tejpar, S., Delorenzi, M., Yan, P., Fiocca, R., Klingbiel, D., Dietrich, D., Biesmans, B., Bodoky, G., Barone, C., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.3452 · Cited by 1,158 · cited 2×
“…(P¼ 0.035) in the senescent group (Figure 1D, inset), suggesting that Ras mutations, if associated with a senescent phenotype, may not necessarily serve as a predictor of poor outcome, as reported by several studies in the past (Benhattar et al, 1993; Andreyev et al, 1998, 2001; Roth et al, 2010).”
ResultInfluential
Cited by
Items 101–121 of 121
Farndale, L., Rakovic, K., Powley, I. R., Hatthakarnkul, P., Seyedshahi, F. A., Jesenakova, S., Santana, L. P. S., Martinelli, S., Ballantyne, F., Officer-Jones, L., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.16.682563 · Cited by 1
“GLB1 is classically used as a protein marker of cellular senescence [28], but the punctate pattern of apical staining we observed in low-grade LUAD is distinct from that often seen in senescence, which appears much more di ! use [29, 30, 31, 32].”
Costa, J. (2015) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
The discovery of a novel, Ras-mediated NORE1A/PMLIV tumor suppressor complex.
Mezzanotte-Sharpe, J. (2016) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/2539
“Indeed, the presence of cellular senescence predicts a better treatment outcome in high-grade colorectal cancer, a finding that corroborated mouse studies from Serrano’s group showing that most premalignant lesions expressing mutant KRAS failed to progress to malignancy and were instead senescent [148, 149].”
Modulating Aged Macrophages and Osteoprogenitors with a Calcium Phosphate Drug Delivery System
Alhamdi, J. R. (2018) · OpenCommons at University of Connecticut (University of Connecticut) · Cited by 1
Rizos, H., & Scurr, L. L. (2011) · Springer eBooks · doi:10.1007/978-3-7091-0371-5_11
Rizos, H., Haferkamp, S., & Scurr, L. L. (2017) · Springer eBooks · doi:10.1007/978-3-319-41319-8_11 · Cited by 1
Narita, M. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735976959.793564895
Tumor-Immunzell-Interaktion und Seneszenz-assoziierte Moleküle im kolorektalen Karzinom
Kellers, F. (2023) · Die Pathologie · doi:10.1007/s00292-023-01267-5
Tatanis, V., Veroutis, D., Pantelis, P., Theocharous, G., Sarlanis, H., Georgiou, A., Peteinaris, A., Νάτσος, Α., Moulavasilis, N., Kavantzas, N., et al. (2024) · Archivio Italiano di Urologia e Andrologia · doi:10.4081/aiua.2024.12246
Pan, B., Zhao, D., Liu, Y., Li, N., Song, C., Li, N., Li, X., Li, M., & Zhao, Z. (2020) · Figshare · doi:10.6084/m9.figshare.12757435
Mourkioti, I., Polyzou, A., Veroutis, D., Theocharous, G., Lаgopati, N., Gentile, E., Stravokefalou, V., Thanos, D.-F., Havaki, S., Kletsas, D., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23803087
Mourkioti, I., Polyzou, A., Veroutis, D., Theocharous, G., Lаgopati, N., Gentile, E., Stravokefalou, V., Thanos, D.-F., Havaki, S., Kletsas, D., et al. (2023) · Discovery Research Portal (University of Dundee) · doi:10.6084/m9.figshare.23803090
Tatanis, V., Veroutis, D., Pantelis, P., Theocharous, G., Sarlanis, H., Georgiou, A., Mulita, F., Peteinaris, A., Νάτσος, Α., Moulavasilis, N., et al. (2024) · Medicina · doi:10.3390/medicina60071108 · Cited by 2
Senescent Epithelial Cells Serve as Invasive Growth Drivers in Ameloblastoma
Lin, H. T., Liang, J.-J., Zhang, C., Man, Q., Li, R., Zhang, L., & Liu, B. (2025) · Laboratory Investigation · doi:10.1016/j.labinv.2025.104227
Yağbasan, F. Ö., Demir, Y. D. Ş., & Ark, M. (2025) · Turkish Journal of Clinics and Laboratory · doi:10.18663/tjcl.1745156
Pan, B., Zhao, D., Liu, Y., Li, N., Song, C., Li, N., Li, X., Li, M., & Zhao, Z. (2020) · Figshare · doi:10.6084/m9.figshare.12757429
Mourkioti, I., Polyzou, A., Veroutis, D., Theocharous, G., Lagopati, N., Gentile, E., Stravokefalou, V., Thanos, D.-F., Havaki, S., Kletsas, D., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23803084
Pan, B., Zhao, D., Liu, Y., Li, N., Song, C., Li, N., Li, X., Li, M., & Zhao, Z. (2020) · Figshare · doi:10.6084/m9.figshare.12757432
Pan, B., Zhao, D., Liu, Y., Li, N., Song, C., Li, N., Li, X., Li, M., & Zhao, Z. (2020) · Figshare · doi:10.6084/m9.figshare.12757426
Nagineni, C. N., Choudhuri, R., Krishna, M. C., & Mitchell, J. B. (2026) · Biomolecules · doi:10.3390/biom16081165
“Thus, senescence can function as a double-edged sword by inhibiting tumor growth by suppressing the proliferation of potential oncogenic cells, or promoting tumor growth, depending on the origin of tumor tissue and spatial and temporal constraints [30–33].”
Garbarino, O., Lambroia, L., Basso, G., Marrella, V., Franceschini, B., Soldani, C., Pasqualini, F., Giuliano, D., Costa, G., Peano, C., et al. (2023) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.10214123
Metadata
- Authors
- Haugstetter, A. M., Loddenkemper, C., Lenze, D., Gröne, J., Standfuß, C., Petersen, I., Dörken, B., & Schmitt, C. A.
- Affiliations
- Stiftung Charité (DE)
- Technical University of Munich (DE)
- Charité – Universitätsmedizin Berlin (DE)
- Freie Universität Berlin (DE)
- Friedrich Schiller University Jena (DE)
- Max Delbrück Center (DE)
- Corresponding author
- Schmitt, C A
- Venue
- British Journal of Cancer
- Published
- 2010-07-13
- Volume
- 103
- Issue
- 4
- Pages
- 505-509
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- PMC
- PMC2939783
- OpenAlex
- W2049256375
- Cited by
- 117
- References
- 28
- Citations by year
- 2026: 2 · 2025: 9 · 2024: 11 · 2023: 16 · 2022: 8 · 2021: 11 · 2020: 9 · 2019: 4 · 2018: 8 · 2017: 6 · 2016: 4 · 2015: 7 · 2014: 5 · 2013: 4 · 2012: 7
- FWCI
- 3.68
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-sa
- www.springer.com/tdm (unspecified)
- Locations
- British Journal of Cancer (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (acceptedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Funders
- Deutsche Krebshilfe
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- cellular senescence, colorectal cancer, metastatic colorectal cancer, treatment outcome prediction, 5-fluorouracil, leucovorin, progression-free survival, cell cycle arrest
- MeSH terms
- Leucovorin, Fluorouracil, Humans, Predictive Value of Tests, Prognosis, Colorectal Neoplasms, Treatment Outcome, Cellular Senescence, Disease-Free Survival
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.